- A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors. Gore, L., Holden, S., Cohen, R., Morrow, M., Pierson, A., O'bryant, C., Persky, M., Gustafson, D., Mikule, C., Zhang, S., Palmer, P., Eckhardt, S. Ann. Oncol. (2006)